Andreas Greischel

Tissue distribution of the novel DPP‐4 inhibitor BI 1356 is dominated by saturable binding to its target in rats

Holger Fuchs, Rudolf Binder, Andreas Greischel · Biopharmaceutics & Drug Disposition · 2009 · 92 citations

Concentration-dependent plasma protein binding of the novel dipeptidyl peptidase 4 inhibitor BI 1356 due to saturable binding to its target in plasma of mice, rats and humans

Holger Fuchs, Jean‐Paul Tillement, Andreas Greischel et al. · Journal of Pharmacy and Pharmacology · 2009 · 89 citations

Binding to dipeptidyl peptidase‐4 determines the disposition of linagliptin (BI 1356) – investigations in DPP‐4 deficient and wildtype rats

Silke Retlich, B. Withopf, Andreas Greischel et al. · Biopharmaceutics & Drug Disposition · 2009 · 46 citations

Molecular Pharmacology, Neuropeptides, Signal Transduction +14

Pharmacokinetics of the M1-agonist talsaclidine in mouse, rat, rabbit and monkey, and extrapolation to man

Andreas Leusch, Wolfgang Tröger, Andreas Greischel et al. · Xenobiotica · 2000 · 25 citations

Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.

Heleen Nicolai, R Brickl, H Eschey et al. · PubMed · 1997 · 24 citations

Metabolic Syndrome, Diabetes Management, Plasma Levels +15